Trial Profile
The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 May 2010
Price :
$35
*
At a glance
- Drugs Fosphenytoin (Primary)
- Indications Brain injuries; Epilepsy; Status epilepticus
- Focus Adverse reactions
- 21 May 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 21 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 May 2009 New trial record